Form 4: JPMorgan CFO Sells Shares Under 10b5-1 Plan

JPMorgan Chase & Co.'s Chief Financial Officer, Jeremy Barnum, sold 2,893 shares of common stock for $312.7859 per share on January 16, 2026, under a pre-arranged trading plan.

Summary

• Jeremy Barnum, Chief Financial Officer of JPMorgan Chase & Co. (JPM), reported a sale of common stock.
• The transaction involved the disposition of 2,893 shares of common stock.
• The sale occurred on January 16, 2026, at a price of $312.7859 per share.
• The transaction was executed pursuant to a Rule 10b5-1(c) trading plan, indicating it was pre-scheduled.
• Following this transaction, Mr. Barnum beneficially owns 26,696 shares of common stock.

Sentiment

Score: 5

Explanation: A neutral score is assigned as this is a routine insider stock sale executed under a pre-arranged 10b5-1 plan, which typically does not carry significant positive or negative implications for the company's operational or financial health. It's a personal financial management event for the executive.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's future performance.

Industry Context

This is a routine insider transaction for a major financial institution. Such sales by executives are common, especially when executed under a Rule 10b5-1 plan, which allows insiders to sell shares at pre-determined times to avoid accusations of trading on material non-public information. It does not inherently reflect on broader industry trends or competitive positioning.

Related Party Transactions

• The transaction involves the sale of common stock by Jeremy Barnum, the Chief Financial Officer of JPMorgan Chase & Co., which is considered an insider transaction.

Stakeholder Impact

• Shareholders may view routine insider sales under 10b5-1 plans as a normal part of executive compensation and personal financial planning, with minimal direct impact on company operations or strategy. However, some investors might interpret any insider sale, even pre-planned, as a slight negative signal, though this is often mitigated by the 10b5-1 context.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-scheduled sale of shares by a CFO under a 10b5-1 plan. Such transactions are common for executives and do not typically signal a change in the company's fundamental outlook or performance. Therefore, it does not warrant a change in investment recommendation based solely on this filing. The overall investment thesis for JPM should remain based on its broader financial performance, market position, and strategic initiatives.

Keywords

JPMorgan Chase, JPM, Insider Trading, Form 4, Stock Sale, CFO, Jeremy Barnum, 10b5-1 Plan